Contents

Search


azilsartan (Edarbi)

azilsartan medoxomil Indications: - treatment of hypertension (chronic hypertension) Contraindications: - pregnancy Dosage: - 80 mg PO QD - 40 mg PO QD in combination with high-dose diuretic Tablets: 40 mg, 80 mg Storage: - store in orginal bottle - sensitive to moisture & light [2] - original container has a desiccant [3]

Interactions

drug adverse effects of angiotensin II receptor antagonists monitor with ARBs

General

angiotensin II receptor antagonist (ARB)

Database Correlations

PUBCHEM correlations

References

  1. FDA NEWS RELEASE, February 25, 2011 FDA approves Edarbi to treat high blood pressure
  2. Prescriber's Letter 18(4): 2011 Comparison of Angiotensin Receptor Blockers Detail-Document#: 270403 (subscription needed) http://www.prescribersletter.com
  3. Prescriber's Letter 21(6): 2014 Oral Meds to Keep in Original Containers Detail-Document#: 300622 (subscription needed) http://www.prescribersletter.com

Component-of

azilsartan/chlorthalidone (Edarbyclor, Takeda)